Sort
48,018 grants matching “immunotherapy”
A Negative Paracrine Loop in Megakaryopoiesis
$377,154Mortimer Poncz · University Of Pennsylvania · P01 · FY2009 · HL
A Negative Paracrine Loop in Megakaryopoiesis
$377,154Mortimer Poncz · University Of Pennsylvania · P01 · FY2010 · HL
A Negative Paracrine Loop in Megakaryopoiesis
$377,154Mortimer Poncz · University Of Pennsylvania · P01 · FY2012 · HL
A Negative Paracrine Loop in Megakaryopoiesis
$377,154Mortimer Poncz · University Of Pennsylvania · P01 · FY2011 · HL
Quantitatively modeling immune responses to cancer
$377,144Matthew Spitzer · University Of California, San Francisco · DP5 · FY2019 · OD
Transfer of the CD40 ligand gene to esophageal carcinoma
$377,138Weill Medical College Of Cornell Univ · R01 · FY2005 · CA
Transfer of the CD40 ligand gene to esophageal carcinoma
$377,138Weill Medical College Of Cornell Univ · R01 · FY2004 · CA
Transfer of the CD40 ligand gene to esophageal carcinoma
$377,138Weill Medical College Of Cornell Univ · R01 · FY2003 · CA
Data Management and Analysis Core
$377,130Aris Floratos · Columbia University Health Sciences · U19 · FY2023 · AI
Project 3: Red cell transfusions and donor T-cell activation in allo-stem cell t
$377,121Edmund K. Waller · Emory University · P01 · FY2015 · HL
Role of Tim-3 in determining T cell immunity
$377,106Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2015 · CA
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$377,088Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2024 · NS
Immunology of human malignant melanoma initiating cells
$377,059Markus H. Frank · Boston Children'S Hospital · R01 · FY2013 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$377,055Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Induction of Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplant
$377,051Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2008 · AI
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma
$377,049Amyn Habib · Ut Southwestern Medical Center · R01 · FY2021 · CA
Innate and Adaptive Anti-Myeloma Immunity
$377,027Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2012 · CA
ALL immunobiology and the bone marrow niche
$377,007Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Programmable Off-the-Shelf Dendritic Cells as an Immunotherapy Discovery Platform
$377,000David Minh Truong · New York University · DP2 · FY2021 · AI
Evaluation of image-guided, conformal, high-dose intraoperative radiation therapy (Precision Breast IORT) for early stage breast cancer
$376,980Shayna Lefrak Showalter · University Of Virginia · R01 · FY2020 · CA
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
$376,976Robert Korngold · Hackensack University Medical Center · R01 · FY2014 · CA
Core B: Computational
$376,975Alan S Perelson · Beth Israel Deaconess Medical Center · P01 · FY2020 · AI
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
$376,962David M. Ashley · Duke University · R01 · FY2023 · CA
GENE EXPRESSION PROFILE OF PROGRESSION &RESPONSE IN CML
$376,920Fred Hutchinson Cancer Research Center · U01 · FY2000 · CA
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$376,909Peter A Cohen · Mayo Clinic Rochester · P50 · FY2016 · CA